Yingying Ning

Professor, South China University of Technology

Spin-X Institute, School of Chemistry and Chemical Engineering / Biomedical Sciences and Engineering

Email: yning@scut.edu.cn

Education and Work Experience

• PI (2023/02-now), Spin-X Institute, South China University of Technology

• Postdoctoral Fellowship (2019-2022), Harvard Medical School / Massachusetts General Hospital (Advisor: Peter Caravan)

• PhD in Inorganic Chemistry (2014-2019), Peking University (Advisor: Jun-Long Zhang)

• B.S. in Chemistry (2010-2014), Renmin University of China (Advisor: Rui Cao)

Awards and Honors

• On the Early Career Board of ACS《Chemical & Biomedical Imaging》

• “Women in Molecular Imaging Network Scholar Award”, WMIC, 2021-2023

• “Young Investigator Award Runner Up”, WMIC, 2022

• “Young Investigator Award”, WMIC, 2021

• “Best Poster Award” in the 23rd International Symposium on the Photochemistry and Photophysics of Coordination Compounds (ISPPCC), 2019

• “100 Excellent Doctoral Thesis” in Peking University, 2019

• National Scholarship for graduates, 2018

  
  

Yingying is a Professor of Chemistry and Biomedical Science at South China University of Technology in Guangzhou. She obtained her undergraduate degree from Renmin University of China in chemistry, where she conducted her undergraduate research in Prof. Rui Cao’s group focusing on biomimetic tri-copper complexes. After graduating from RUC in 2014, Yingying joined the group of Prof. Jun-Long Zhang at Peking University. Her PhD research focused on developing highly luminescent lanthanide complexes for NIR imaging-guided theranostics. In 2019, after finishing PhD, she went to United States and carried out her post-doc research in Prof. Peter Caravan’s lab. She was trained in translational medicine then and successfully developed a series of MRI contrast agents for specifically imaging liver fibrogenesis. Yingying has filed more than 5 patents and 3 granted patents have been transferred to different companies. Currently, Yingying is a new PI at SCUT. Her research interest lies in the field that using chemistry tools to develop and translate metal-based complexes to diagnose and treat diseases in the early stage, helping to track molecular events in vivo and giving guidance to clinic theranostic.